Godavari Biorefineries' IPO Seizes Investor Attention with Robust Subscription
Godavari Biorefineries Ltd's IPO gained significant traction, with subscriptions reaching 1.83 times the offer. The Rs 555-crore public offering included both fresh equity shares and an offer-for-sale by promoters. Proceeds will facilitate debt repayment and corporate purposes for the ethanol and bio-based chemicals maker.
- Country:
- India
The public offering of Godavari Biorefineries Ltd, an ethanol and bio-based chemicals producer, closed with a strong 1.83 times subscription on its final bidding day.
The Rs 555-crore IPO, held on Friday, attracted bids for over 2 crore shares against 1.12 crore shares on offer, according to NSE data. Qualified Institutional Buyers (QIBs) showed strong interest with a 2.76 times subscription, and Retail Individual Investors (RIIs) subscribed 1.71 times, though non-institutional investors lagged slightly with 90 per cent.
The IPO comprises a fresh issue of equity shares worth Rs 325 crore and an offer-for-sale worth Rs 230 crore. Godavari Biorefineries plans to use Rs 240 crore from proceeds to repay debt, with the remainder supporting corporate activities. Key industries benefiting from its wide-ranging products include pharmaceuticals, food, and power.
(With inputs from agencies.)
ALSO READ
European Markets Surge Amid Economic Data and Corporate Gains
Alembic Pharmaceuticals Gains USFDA Approval for Hypertension Treatment
Niva Bupa Health Insurance IPO Sees Strong Subscription
Health Sector in Focus: Key Developments in Pharmaceuticals and Policy
Health News Roundup: Key Developments in Pharmaceuticals and Public Health